SASVX
Price
$8.00
Change
+$0.03 (+0.38%)
Updated
Jul 31 closing price
Net Assets
110.9M
VSCIX
Price
$141.38
Change
-$0.34 (-0.24%)
Updated
Jul 31 closing price
Net Assets
188.57B
Interact to see
Advertisement

SASVX vs VSCIX

SASVX vs VSCIX Comparison Chart in %
View a ticker or compare two or three
VS
SASVX vs. VSCIX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SASVX is a Hold and VSCIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSCIX has more cash in the bank: 189B vs. SASVX (111M). VSCIX pays higher dividends than SASVX: VSCIX (1.23) vs SASVX (0.61). SASVX was incepted earlier than VSCIX: SASVX (23 years) vs VSCIX (29 years). SASVX (1.46) is less costly to investors than VSCIX (0.03). SASVX is a more actively managed with annual turnover of: 77.00 vs. VSCIX (17.00). SASVX has a lower initial minimum investment than VSCIX: SASVX (2500) vs VSCIX (5000000). SASVX annual gain was more profitable for investors over the last year : 27.06 vs. VSCIX (22.58). VSCIX return over 5 years is better than : 35.13 vs. SASVX (-22.66).
SASVXVSCIXSASVX / VSCIX
Total Expense Ratio1.410.034,700%
Annual Report Gross Expense Ratio1.460.034,867%
Fund Existence23 years29 years-
Gain YTD19.17114.591131%
Front Load6%N/A-
Min. Initial Investment250050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets111M189B0%
Annual Yield % from dividends0.611.2350%
Returns for 1 year27.0622.58120%
Returns for 3 years6.4343.4415%
Returns for 5 years-22.6635.13-65%
Returns for 10 years-26.29156.07-17%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GSPKX20.050.12
+0.60%
Goldman Sachs US Eq Div and Prem Instl
GSIQX23.62N/A
N/A
Goldman Sachs GQG Ptnrs Intl Opps R
HSIIX29.59-0.08
-0.27%
Carillon Eagle Small Cap Growth I
CCWSX21.56-0.16
-0.74%
Baird Chautauqua International Gr Inv
RYCFX49.56-1.15
-2.27%
Rydex Biotechnology C